Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Losartan in Hypertensive Men With Obstructive Sleep Apnea
2008-000869-38Phase 4Active
- Sponsor
- Skaraborgs sjukhus
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of losartan in hypertension (HTN) and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Skaraborgs sjukhus. Primary endpoint: Change in 24-hour ambulatory blood pressure after 6 weeks of losartan. Started Mar 2008; status: active.
02
Drugs
losartan
03
Conditions
hypertension (HTN)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2008-000869-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000869-38.